USE OF GENETICALLY DYSTROPHIC ANIMALS IN CHEMOTHERAPY TRIALS AND APPLICATION OF SEROTONIN ANTAGONISTS AS ANTIDYSTROPHIC DRUGS

Abstract
No abstract available